Ro launches the GLP-1 Supply Tracker Tool gives patients real-time insights on GLP-1 drug shortages and automated, localized supply alerts May 29, 2024 Ro , the leading direct-to-patient healthcare company, today launched the GLP-1 Supply Tracker, an interactive tool to give patients real-time insights on GLP-1 drug shortages and automated, localized supply alerts
Purpose-built for physicians Combination bimagrumab plus semaglutide confers weight loss while preserving lean mass Key takeaways: Adding bimagrumab 30 mg/kg to semaglutide 2.4 mg conferred weight loss of more than 20% at 72 weeks in patients with obesity
Most side effects fade as the dose wears off and often lessen with use
But it is only one third of what retatrutide does
Systemic Inflammation: Chronic platelet activation may drive systemic inflammatory cascades
Same category as MTC, this is an absolute contraindication